-
-
-
-
-
-
-
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial ResultsĀ
-
-
-
-
-
-
-
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
-
-
-
-
-
-
-
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
-
-
-
-
-
-
-
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
-
-
-
-
-
-
-
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
-
-
-
-
-
-
-
22nd Century Group (XXII) Issues Annual Letter to Shareholders
-
-
-
-
-
-
-
Former Santa Fe Natural Tobacco Company Executive Joins 22nd Century
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

